Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • ADC Linker
    (2)
  • E3 Ligase Ligand-Linker Conjugate
    (2)
  • PROTAC Linker
    (2)
  • CDK
    (1)
  • Drug-Linker Conjugates for ADC
    (1)
  • Huntingtin
    (1)
  • Ligand for E3 Ligase
    (1)
  • Others
    (3)
Filter
Search Result
Results for "

c2 8

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    10
    TargetMol | Inhibitors_Agonists
  • PROTAC Products
    6
    TargetMol | PROTAC
  • Recombinant Protein
    5
    TargetMol | Recombinant_Protein
C2-8
C2-8
T38279300670-16-0
C2-8 is an inhibitor of polyglutamine (polyQ) aggregation with IC50s of 25 and 0.05 μM for recombinant HDQ51 and in PC12 cells, respectively. It also limits polyQ aggregation in organotypic hippocampal slice cultures from R6/2 transgenic mice and reduces neurodegeneration dose-dependently in a Drosophila model of Huntington's disease. C2-8 (100 and 200 mg/kg) decreases huntingtin aggregate size, reduces neuronal atrophy, and enhances motor performance in a rotarod test in the R6/2 transgenic mouse model of Huntington's disease.
  • $113
35 days
Size
QTY
TLR7/8 agonist 12-PAB-(PEG4-Me)-Cit-Val-PEG2-amide-C2-MC
T2106263080930-77-1
TLR7/8 agonist 12-PAB-(PEG4-Me)-Cit-Val-PEG2-amide-C2-MC (compound LIV1-IMC (12) linker-payload) serves as a linker-payload conjugate designed for the synthesis of antibody-drug conjugates (ADCs). This structure incorporates a TLR7/8 agonist (ADC payload) along with a linker.
  • Inquiry Price
Backorder
Size
QTY
Palbociclib
PD 0332991
T1785571190-30-2
Palbociclib (PD 0332991) is a CDK inhibitor that inhibits CDK4 and CDK6 (IC50=11/16 nM) and is orally active. Palbociclib has anti-tumorigenic activity and has investigational potential for use in ER-positive and HER2-negative breast cancer.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
Cbz-NH-PEG8-C2-acid
T148921334177-87-5
Cbz-NH-PEG8-C2-acid is a PEG-based linker for PROTACs that joins two essential ligands, facilitating selective protein degradation via the ubiquitin-proteasome system within cells.
  • Inquiry Price
7-10 days
Size
QTY
Mal-amido-PEG8-C2-acid
T159611334177-86-4
Mal-amido-PEG8-C2-acid (US2018339985, example 142) is a noncleavable linker for antibody-drug conjugates (ADCs) [1].
  • $46
Inquiry
Size
QTY
Pomalidomide-PEG3-C2-NH2 (TFA)
Pomalidomide-PEG3-C2-NH2 (TFA) (2093416-31-8 free base), E3 ligase Ligand-Linker Conjugates 30 (TFA), Cereblon Ligand-Linker Conjugates 5 (TFA)
T17882
Pomalidomide-PEG3-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology.
  • Inquiry Price
Backorder
Size
QTY
Pomalidomide-PEG4-C2-NH2
E3 Ligase Ligand-Linker Conjugates 22, Cereblon Ligand-Linker Conjugates 8
T179162225940-52-1
Pomalidomide-PEG4-C2-NH2 (E3 Ligase Ligand-Linker Conjugates 22) is a synthesized E3 ligase ligand-linker conjugate incorporating the Pomalidomide-based cereblon ligand and 4-unit PEG linker.
  • $30
In Stock
Size
QTY
Pomalidomide-C2-Br
T2035922940940-74-7
Pomalidomide-C2-Br is a conjugate of an E3 ligase ligand and a linker. It is used in the synthesis of PROTACAR Degrader-8.
  • Inquiry Price
Backorder
Size
QTY
PAB-(PEG4-Me)-Cit-Val-PEG2-amide-C2-MC
T211257
PAB-(PEG4-Me)-Cit-Val-PEG2-amide-C2-MC is an ADC linker that can be combined with TLR7/8 agonists to create linker-payload conjugates.
  • Inquiry Price
Backorder
Size
QTY
Adamantan-C-amide-PEG2-C2-amine
T2123941577212-91-9
Adamantan-C-amide-PEG2-C2-amine (Compound 8) is a PROTAC linker belonging to the PEG class, used in the synthesis of PROTAC molecules, such as PROTACβ-NF-JQ1.
    Inquiry
    Inquiry